β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors

PPARγ Agonist Curcumin Reduces the Amyloid-β-Stimulated Inflammatory Responses in Primary Astrocytes

(2017) Hong-Mei Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide

(2011) Caterina Scuderi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?

(2010) Christopher J. Fowler et al.   EXPERIMENTAL NEUROLOGY

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury

(2010) Partha Mukhopadhyay et al.   FREE RADICAL BIOLOGY AND MEDICINE

Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons

(2010) Janis Noonan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase

(2010) Jonathan Z. Long et al.   JOURNAL OF LIPID RESEARCH

CCL2 modulates cytokine production in cultured mouse astrocytes

(2010) Bridgette D Semple et al.   Journal of Neuroinflammation

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

Intracellular trafficking of anandamide: new concepts for signaling

(2010) Mauro Maccarrone et al.   TRENDS IN BIOCHEMICAL SCIENCES

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease

(2009) Qingguang Jiang et al.   CNS DRUGS

Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF-κB

(2009) Fernando Correa et al.   GLIA

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

(2009) Jeannie Hwang et al.   LIFE SCIENCES

Anandamide Increases the Differentiation of Rat Adipocytes and Causes PPARγ and CB1 Receptor Upregulation

(2009) Sevasti Karaliota et al.   Obesity

The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine

(2009) Sherry Shu-Jung Hu et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond

(2008) Roger G. Pertwee   ADDICTION BIOLOGY

The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes

(2008) M. Vignali et al.   GLIA

Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome

(2008) E. Núñez et al.   NEUROSCIENCE

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors

(2007) S E O'Sullivan   BRITISH JOURNAL OF PHARMACOLOGY